Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. (Q30356651)

18 August 2017

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. (English)

1 reference

Middle East respiratory syndrome coronavirus

18 August 2017

0 references

1 reference

1 reference

1 reference

16

Gail Carson

1 reference

18 August 2017

11

Frederick G Hayden

1 reference

18 August 2017

Yaseen M Arabi

1

1 reference

18 August 2017

Ali H Hajeer

2

1 reference

18 August 2017

Thomas Luke

3

1 reference

18 August 2017

Kanakatte Raviprakash

4

1 reference

18 August 2017

Hanan Balkhy

5

1 reference

18 August 2017

Sameera Johani

6

1 reference

18 August 2017

Abdulaziz Al-Dawood

7

1 reference

18 August 2017

Saad Al-Qahtani

8

1 reference

18 August 2017

Awad Al-Omari

9

1 reference

18 August 2017

Fahad Al-Hameed

10

1 reference

18 August 2017

Robert Fowler

12

1 reference

18 August 2017

Abderrezak Bouchama

13

1 reference

18 August 2017

Nahoko Shindo

14

1 reference

18 August 2017

Khalid Al-Khairy

15

1 reference

18 August 2017

Yusri Taha

17

1 reference

18 August 2017

Musharaf Sadat

18

1 reference

18 August 2017

Mashail Alahmadi

19

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 September 2016

1 reference

Emerging Infectious Diseases

18 August 2017

1 reference

18 August 2017

22

1 reference

18 August 2017

9

1 reference

18 August 2017

1554-1561

1 reference

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Transmission of MERS-coronavirus in household contacts

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

MERS coronaviruses in dromedary camels, Egypt.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

SARS: systematic review of treatment effects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

The time course of the immune response to experimental coronavirus infection of man.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Use of convalescent plasma therapy in SARS patients in Hong Kong

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4994343

Disappearance of antibodies to SARS-associated coronavirus after recovery

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27532807

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Successful treatment of avian influenza with convalescent plasma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27532807

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3201/EID2209.151164

1 reference

18 August 2017

1 reference

18 August 2017

1 reference